Summary
This PRA Insights report focusing on Alzheimer’s disease research was compiled from survey data gathered at the 2017 Alzheimer’s Association International Conference (AAIC). The aim of the survey was to gather insight on clinical development and the future of research in Alzheimer’s disease from pharma and biotech, academic researchers, next generation investigators, clinicians and the care research community involved in the prevention and treatment of Alzheimer’s disease and other dementias.
Register to download
PRA Insights Report: Alzheimer's Disease Research
You may also be interested in:
Poster
Select Characteristics of Recreational Opioid Users Undergoing a Human Abuse Potential Study
Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to…
Poster
A Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Outpatient Clinical Trials in Subjects with Schizophrenia or Schizoaffective Disorder
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in a meta-analysis to be as high as 76%. The…
Fact Sheet
CSF Sampling
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK…